Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -8.64 | 25.30 |
| PEG Ratio (TTM) | -0.70 | 1.79 |
| P/S Ratio (TTM) | 0.38 | 2.02 |
| P/B Ratio (TTM) | 0.91 | 1.05 |
| P/FCF Ratio (TTM) | 28.99 | 15.48 |
| Price to 5YR AVG Earnings Ratio | N/A | 15.37 |
| Price to 5YR AVG FCF Ratio | N/A | 23.80 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.01% | 5.74% |
| ROE (TTM) | -10.11% | 8.83% |
| Net Profit Margin (TTM) | -4.43% | 6.36% |
| ROIC 5YR AVG | N/A | 8.93% |
Growth (37%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.15% | -196.96% | N/A |
| Revenue | 1.06% | 24.69% | N/A |
| Net Income | 3.71% | -193.51% | N/A |
| Cash Flow | 165.43% | 875.40% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.95 | 1.52 |
| Quick Ratio (TTM) | 1.36 | 0.90 |
| D/E Ratio (TTM) | 1.87 | 0.69 |
| Interest Coverage (TTM) | 0.89 | 14.45 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 1.05 | 3.19 |
| LTL to 5YR AVG FCF | N/A | 6.95 |
| Shares Outstanding Growth 5YR AVG | N/A | 1.91% |